Home

lucht Empirisch Geweldige eik lawsuit teva Benadrukken Varken vernieuwen

DOJ accuses drugmaker Teva of illegal kickbacks to inflate prices | Fox  Business
DOJ accuses drugmaker Teva of illegal kickbacks to inflate prices | Fox Business

Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ

Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement -  Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg

Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News

Teva reaches $21m settlement with Rhode Island over opioid-related claims |  The Times of Israel
Teva reaches $21m settlement with Rhode Island over opioid-related claims | The Times of Israel

Teva ponies up $420M to settle with investors who said company hid  price-fixing scheme | Fierce Pharma
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma

J&J, Teva and Other Opioid Drugmakers Face $50 Billion Lawsuit in  California | BioSpace
J&J, Teva and Other Opioid Drugmakers Face $50 Billion Lawsuit in California | BioSpace

Teva to Pay $420M to Settle Shareholders' Generic Drug Pricing Lawsuit —  Report - TipRanks.com
Teva to Pay $420M to Settle Shareholders' Generic Drug Pricing Lawsuit — Report - TipRanks.com

Allergan, Teva to pay $54M in San Francisco opioid lawsuit
Allergan, Teva to pay $54M in San Francisco opioid lawsuit

Teva Pharmaceuticals at heart of major price fixing suit in US -  www.israelhayom.com
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com

Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes -  Pharma Technology Focus | Issue 85 | August 2019
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019

Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says |  Ctech
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says | Ctech

Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug -  The New York Times
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times

Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN  Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business

Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters

Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals is found liable in the opioid crisis : NPR

Tentative $161.5 million settlement reached in opioid trial
Tentative $161.5 million settlement reached in opioid trial

Teva to pay $523 mln to New York as it looks to move past opioid lawsuits |  Reuters
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters

California judge rules for Israeli Teva in major opioid lawsuit - The  Jerusalem Post
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post

Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business  Journal
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal

Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York  Times
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times

Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters